OMED

OncoMed Pharmaceuticals, Inc.

OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

68 hedge funds and large institutions have $65.1M invested in OncoMed Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 26 reducing their positions, and 29 closing their positions.

2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3

Holders

Holders Change

-17

Holders Change %

-20%

% of All Funds

1.7%

Holding in Top 10

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

0.02%

New

Increased

Reduced

Closed

Calls

$1K

Puts

$222K

Net Calls

-$221K

Net Calls Change

-$4.6M

Top Buyers

1	1 Primecap Management Pasadena, California	$18.5M
2	BI 2 BVF Inc San Francisco, California	$14.7M
3	3 Ameriprise Minneapolis, Minnesota	$3.22M
4	MWNA 4 Marshall Wace North America New York	$561K
5	5 Two Sigma Investments New York	$439K

Top Sellers

1	1 Fidelity Investments Boston, Massachusetts	$0
2	2 Franklin Resources San Mateo, California	$0
3	3 BlackRock New York	$2.6M
4	4 State Street Boston, Massachusetts	$44K
5	5 Northern Trust Chicago, Illinois	$255K

#	Name	Market Value	Shares	Shares Change	Shares Change %
26	26 Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada	$233K	70,100	+70,100	New
27	27 Barclays London, United Kingdom	$222K	66,661	+19,762	+42%
28	LP 28 LMR Partners London, United Kingdom	$201K	60,347	+60,347	New
29	ARTA 29 A.R.T. Advisors New York	$197K	59,360	+46,624	+366%
30	30 D.E. Shaw & Co New York	$185K	55,467	+33,623	+154%
31	31 Susquehanna International Group Bala Cynwyd, Pennsylvania	$177K	53,124	-6,678	-11%
32	NSEDCP 32 NJ State Employees Deferred Compensation Plan Trenton, New Jersey	$160K	48,000	–	–
33	33 Charles Schwab San Francisco, California	$154K	46,012	-35,987	-44%
34	34 Citadel Advisors Miami, Florida	$154K	45,997	+45,997	New
35	CS 35 Credit Suisse Zurich, Switzerland	$149K	44,484	-38,846	-47%
36	GT 36 Glenmede Trust Philadelphia, Pennsylvania	$118K	12,900	–	–
37	BC 37 Birchview Capital Burlington, Vermont	$96K	28,689	-6,000	-17%
38	38 Morgan Stanley New York	$95K	28,579	-24,268	-46%
39	TI 39 Turner Investments Berwyn, Pennsylvania	$83K	24,783	-13,300	-35%
40	ZIM 40 Zacks Investment Management Chicago, Illinois	$80K	23,997	-68	-0.3%
41	41 Bank of New York Mellon New York	$78K	23,539	-85,734	-78%
42	VKH 42 Virtu KCG Holdings New York	$77K	23,125	+11,975	+107%
43	43 Tudor Investment Corp Stamford, Connecticut	$76K	22,900	+22,900	New
44	44 ProShare Advisors Bethesda, Maryland	$64K	19,312	-2,928	-13%
45	45 Squarepoint New York	$64K	19,251	+19,251	New
46	46 Deutsche Bank Frankfurt Am Main Ge, Germany	$63K	19,396	-98,489	-84%
47	47 State Street Boston, Massachusetts	$44K	13,100	-339,212	-96%
48	48 Baird Financial Group Milwaukee, Wisconsin	$40K	12,000	–	–
49	49 Two Sigma Advisers New York	$39K	11,800	+11,800	New
50	TRCT 50 Tower Research Capital (TRC) New York	$38K	11,490	+8,099	+239%

OncoMed Pharmaceuticals, Inc. OMED

Top Buyers

Top Sellers

OncoMed Pharmaceuticals, Inc.

OMED